145 related articles for article (PubMed ID: 12073130)
1. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine.
Maranga L; Rueda P; Antonis AF; Vela C; Langeveld JP; Casal JI; Carrondo MJ
Appl Microbiol Biotechnol; 2002 Jun; 59(1):45-50. PubMed ID: 12073130
[TBL] [Abstract][Full Text] [Related]
2. A novel recombinant virus-like particle vaccine for prevention of porcine parvovirus-induced reproductive failure.
Antonis AF; Bruschke CJ; Rueda P; Maranga L; Casal JI; Vela C; Hilgers LA; Belt PB; Weerdmeester K; Carrondo MJ; Langeveld JP
Vaccine; 2006 Jun; 24(26):5481-90. PubMed ID: 16730104
[TBL] [Abstract][Full Text] [Related]
3. Virus-like particle production at low multiplicities of infection with the baculovirus insect cell system.
Maranga L; Brazão TF; Carrondo MJ
Biotechnol Bioeng; 2003 Oct; 84(2):245-53. PubMed ID: 12966582
[TBL] [Abstract][Full Text] [Related]
4. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
[TBL] [Abstract][Full Text] [Related]
5. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
[TBL] [Abstract][Full Text] [Related]
6. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles.
Rueda P; Fominaya J; Langeveld JP; Bruschke C; Vela C; Casal JI
Vaccine; 2000 Nov; 19(7-8):726-34. PubMed ID: 11115693
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of swine with an inactivated porcine parvovirus vaccine in the presence of passive immunity.
Paul PS; Mengeling WL
J Am Vet Med Assoc; 1986 Feb; 188(4):410-3. PubMed ID: 3949618
[TBL] [Abstract][Full Text] [Related]
8. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
[TBL] [Abstract][Full Text] [Related]
9. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
[TBL] [Abstract][Full Text] [Related]
10. Development of recombinant porcine parvovirus-like particles as an antigen carrier formed by the hybrid VP2 protein carrying immunoreactive epitope of porcine circovirus type 2.
Pan Q; He K; Huang K
Vaccine; 2008 Apr; 26(17):2119-26. PubMed ID: 18378364
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
12. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield.
Chung CY; Chen CY; Lin SY; Chung YC; Chiu HY; Chi WK; Lin YL; Chiang BL; Chen WJ; Hu YC
Vaccine; 2010 Oct; 28(43):6951-7. PubMed ID: 20797455
[TBL] [Abstract][Full Text] [Related]
13. Downstream processing of triple layered rotavirus like particles.
Peixoto C; Sousa MF; Silva AC; Carrondo MJ; Alves PM
J Biotechnol; 2007 Jan; 127(3):452-61. PubMed ID: 16959354
[TBL] [Abstract][Full Text] [Related]
14. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
[TBL] [Abstract][Full Text] [Related]
15. Production of functional hepatocyte growth factor (HGF) in insect cells infected with an HGF-recombinant baculovirus in a serum-free medium.
Wang MY; Yang YH; Lee HS; Lai SY
Biotechnol Prog; 2000; 16(2):146-51. PubMed ID: 10753438
[TBL] [Abstract][Full Text] [Related]
16. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus.
Ostanello F; Caprioli A; Di Francesco A; Battilani M; Sala G; Sarli G; Mandrioli L; McNeilly F; Allan GM; Prosperi S
Vet Microbiol; 2005 Jul; 108(3-4):179-86. PubMed ID: 15916871
[TBL] [Abstract][Full Text] [Related]
17. Development of a subunit vaccine for infectious pancreatic necrosis virus using a baculovirus insect/larvae system.
Shivappa RB; McAllister PE; Edwards GH; Santi N; Evensen O; Vakharia VN
Dev Biol (Basel); 2005; 121():165-74. PubMed ID: 15962479
[TBL] [Abstract][Full Text] [Related]
18. Modeling rotavirus-like particles production in a baculovirus expression vector system: Infection kinetics, baculovirus DNA replication, mRNA synthesis and protein production.
Roldão A; Vieira HL; Charpilienne A; Poncet D; Roy P; Carrondo MJ; Alves PM; Oliveira R
J Biotechnol; 2007 Mar; 128(4):875-94. PubMed ID: 17289202
[TBL] [Abstract][Full Text] [Related]
19. Investigation of Kluyveromyces marxianus as a novel host for large-scale production of porcine parvovirus virus-like particles.
Yang D; Chen L; Duan J; Yu Y; Zhou J; Lu H
Microb Cell Fact; 2021 Jan; 20(1):24. PubMed ID: 33494762
[TBL] [Abstract][Full Text] [Related]
20. Optimization of chimeric HIV-1 virus-like particle production in a baculovirus-insect cell expression system.
Pillay S; Meyers A; Williamson AL; Rybicki EP
Biotechnol Prog; 2009; 25(4):1153-60. PubMed ID: 19572400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
